SCHEMBL351554

SCHEMBL351554

C=CCOCC(=C)C(=O)OC1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.36
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
NAAA Q02083 2/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
HTT P42858 1/20 0.33
CYP19A1 P11511 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CASP1 P29466 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL352819 0.98 EPHX1 (0.33) EPHX1CYP2C19ALDH1A1GAANAAA
SCHEMBL1520936 0.87 EPHX1 (0.42) EPHX1CYP2C19NAAAHTTCYP19A1
SCHEMBL353056 0.85 CYP19A1 (0.34) CYP19A1
SCHEMBL352685 0.81 ALDH1A1 (0.33) ALDH1A1GAANAAANPC1
SCHEMBL352105 0.81 APOBEC3A (0.39) GAANPC1MAPTRAB9AHTT
SCHEMBL8996569 0.81 EPHX1 (0.38) EPHX1CYP2C19NAAAHTTCYP19A1
SCHEMBL20261871 0.81 EPHX1 (0.38) EPHX1CYP2C19NAAAHTTCYP19A1
SCHEMBL352563 0.80 EPHX1 (0.33) EPHX1CYP2C19ALDH1A1GAANAAA
SCHEMBL19837887 0.80 NAAA (0.32) ALDH1A1GAANAAA
SCHEMBL25432986 0.79 EPHX1 (0.40) EPHX1CYP2C19NAAAHTTCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024128086-A1 CURABLE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING LAMINATE 富士フイルム株式会社 2024-06-20 WO disclosed
US-11987658-B2 Curable resin composition and method of manufacturing article CANON KABUSHIKI KAISHA (JP) 2024-05-21 US disclosed
WO-2024019140-A1 COMPOSITION 株式会社日本触媒 2024-01-25 WO disclosed
WO-2024019139-A1 COMPOSITION 株式会社日本触媒 2024-01-25 WO disclosed
WO-2023248976-A1 POLYMER AND METHOD FOR PRODUCING SAME, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, AND MONOMER COMPOUND AND METHOD FOR PRODUCING SAME 株式会社日本触媒 2023-12-28 WO disclosed
CN-117062716-A Laminate body 琳得科株式会社 2023-11-14 CN disclosed
US-11793732-B2 Dental materials based on cyclopolymerizable crosslinkers IVOCLAR VIVADENT AG (LI) 2023-10-24 US disclosed
CN-113226746-B Gas barrier laminate 琳得科株式会社 2023-08-11 CN disclosed
US-20230240947-A1 DENTAL ADHESIVE COMPOSITION AND DENTAL MATERIAL MITSUI CHEMICAIS, INC. (JP) 2023-08-03 US disclosed
WO-2023127300-A1 NON-AQUEOUS SECONDARY BATTERY BINDER POLYMER, NON-AQUEOUS SECONDARY BATTERY BINDER COMPOSITION, AND NON-AQUEOUS SECONDARY BATTERY ELECTRODE 株式会社レゾナック 2023-07-06 WO disclosed
CN-102365260-B a-(unsaturated alkoxyalkyl)acrylate composition and process for production thereof NIPPON CATALYTIC CHEM IND 2015-04-15 CN disclosed
EP-2415751-B1 ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF NIPPON CATALYTIC CHEM IND (JP) 2014-11-26 EP disclosed
US-8796492-B2 α-(unsaturated alkoxyalkyl) acrylate composition and process for production thereof NIPPON SHOKUBAI CO., LTD. (JP) 2014-08-05 US disclosed
EP-2383317-B1 ALPHA-ALLYLOXYMETHYLACRYLIC ACID-BASED COPOLYMER, RESIN COMPOSITION, AND USE THEREOF NIPPON CATALYTIC CHEM IND (JP) 2013-10-23 EP disclosed
US-8497332-B2 α-Allyloxymethylacrylic acid-based copolymer, resin compositions, and use thereof NIPPON SHOKUBAI CO., LTD. (JP) 2013-07-30 US disclosed
CN-102365260-A a-(unsaturated alkoxyalkyl)acrylate composition and process for production thereof NIPPON CATALYTIC CHEM IND 2012-02-29 CN disclosed
EP-2415751-A1 ALPHA-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF Nippon Shokubai Co., Ltd. (JP) 2012-02-08 EP disclosed
US-20120016095-A1 a-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2012-01-19 US disclosed
EP-2383317-A1 ALPHA-ALLYLOXYMETHYLACRYLIC ACID-BASED COPOLYMER, RESIN COMPOSITION, AND USE THEREOF Nippon Shokubai Co., Ltd. (JP) 2011-11-02 EP disclosed
US-20110263805-A1 ALPHA-ALLYLOXYMETHYLACRYLIC ACID-BASED COPOLYMER, RESIN COMPOSITIONS, AND USE THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11793732-B2 Dental materials based on cyclopolymerizable crosslinkers CBR3, CBR1, C1R EPHX1 924/4885CYP2C19 254/4885ALDH1A1 2217/4885
US-20230240947-A1 DENTAL ADHESIVE COMPOSITION AND DENTAL MATERIAL CAD, CDH1, ITGA1 EPHX1 684/4885CYP2C19 2617/4885ALDH1A1 435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.